In Flagstaff, Arizona on June 24, 2026, Corvention, a prominent company in structural heart advancements, reported the completion of the initial procedure in the U.S. employing its exclusive KardiaPSI™ balloon catheter. This significant achievement marked a milestone for Corvention in advancing cardiac healthcare technology.